Infectociprocort (Ciprofloxacin, Fluocinolone Acetonide)

Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication. By blocking these targets, the drug prevents bacterial cell division and leads to bacterial death, providing broad‑spectrum activity against the organisms that commonly cause ear infections.

The dosage and duration of Infectociprocort are determined by the prescribing clinician based on the severity of the infection, patient age, and ear condition. Patients should follow the exact instructions on the prescription label and consult their healthcare provider for any clarification.

Safety in pregnancy and lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare professional before using Infectociprocort.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Infectociprocort offers a dual mechanism: a fluoroquinolone antibiotic for bacterial eradication and a corticosteroid for inflammation reduction. This combination can be more convenient than using separate antibiotic and steroid drops, potentially improving adherence and providing faster symptom relief.

Store Infectociprocort at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

The preparation is applied directly into the affected ear(s) as a few drops, usually several times daily, according to the prescribing physician’s instructions. The patient should lie with the treated ear facing upward for a short period after instillation to allow adequate contact with the canal.

Serious risks include allergic reactions such as rash, swelling, or breathing difficulty, and ototoxicity that can lead to permanent hearing loss, especially when used with other ototoxic medications. Patients should seek immediate medical attention if they experience severe ear pain, dizziness, or signs of an allergic response.

Infectociprocort should be avoided in individuals with a known hypersensitivity to ciprofloxacin, fluocinolone acetonide, or any component of the formulation. It is also contraindicated in patients with a perforated tympanic membrane unless specifically directed by a physician.